The value of ~(99)Tc~m-MIBI scintigraphy in differentiative diagnosis of malignant and benign bone lesions of appendicular skeleton

GUO Yong,Li Xiao-hong

2011-01-01

Abstract:Objective 99Tc+m-methoxyisobutylisonitrile(MIBI) in differentiate diagnosis of malignant and benign bone lesions of appendicular skeleton and in the assessment of tumor response to chemotherapy.Methods Fifty one patients with various bone pathologies [22 osteosarcoma,12 giant cell tumor,6 chondrosarcoma,3 non-Hodgkin′s lymphoma(NHL),2 malignant synovioma,2 osteochondroma,1 osteomyelitis] were examined with both imaging agents Planar 99Tc+m-MIBI scintigraphy was performed 30 min and 120 min after injection of 740 MBq Within 2 days,99Tc+m-MDP three phase(blood flow,blood pool and delaied scan) were tested.Results With 51 cases of appendicular skeleton lesions bone,the sensitivity of three-phase imaging was the highest(96.4%),but 99Tc+m-MIBI intimate the specificity of the tumor was highest(91.4%),bone three-phase results and 99Tc+m-MIBI kiss tumor early imaging result has high consistency(78.3%).In quantitative analysis of 99Tc+m-MIBI early scan,the mean Tumor/contra lateral(T/C) ratio of malignant lesions(3.64±1.83) was significantly higher than that of benign counterparts(2.21±0.89,P<0.01),but infect did not uptake 99Tc+m-MIBI.Conclusion 99Tc+m-MIBI imaging has a good reflection of the effectiveness of therapy,Combined application of two imaging agents can provide best clinical value in differentiate diagnosis and in evaluation of the therapy of malignant and benign bone lesions.